Kim Joo-Hee, Shin Kyung Eun, Chang Hun Soo, Lee Jong-Uk, Park Seung-Lee, Park Jai Soung, Park Jong Sook, Park Choon-Sik
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Allergy Asthma Immunol Res. 2023 Mar;15(2):174-185. doi: 10.4168/aair.2023.15.2.174.
A subset of asthmatics suffers from persistent airflow limitation, known as remodeled asthma, despite optimal treatment. Typical quantitative scoring methods to evaluate structural changes of airway remodeling on high-resolution computed tomography (HRCT) are time-consuming and laborious. Thus, easier and simpler methods are required in clinical practice. We evaluated the clinical usefulness of a simple, semi-quantitative method based on 8 HRCT parameters by comparing asthmatics with a persistent decline of post-bronchodilator (BD)-FEV1 to those with a BD-FEV1 that normalized over time and evaluated the relationships of the parameters with BD-FEV1.
Asthmatics (n = 59) were grouped into 5 trajectories (Trs) according to the changes of BD-FEV1 over 1 year. After 9-12 months of guideline-based treatment, HRCT parameters including emphysema, bronchiectasis, anthracofibrosis, bronchial wall thickening (BWT), fibrotic bands, mosaic attenuation on inspiration, air-trapping on expiration, and centrilobular nodules were classified as present (1) or absent (0) in 6 zones.
The Tr5 group (n = 11) was older and exhibited a persistent decline in BD-FEV1. The Tr5 and Tr4 groups (n = 12), who had a lower baseline BD-FEV1 that normalized over time, had longer durations of asthma, frequent exacerbations, and higher doses of steroid use compared to the Tr1-3 groups (n = 36), who had a normal baseline BD-FEV1. The Tr5 group had higher emphysema and BWT scores than the Tr4 ( = 8.25E-04 and = 0.044, respectively). Scores for the other 6 parameters were not significantly different among the Tr groups. BD-FEV1 was inversely correlated with the emphysema and BWT scores in multivariate analysis ( = 1.70E-04, = 0.006, respectively).
Emphysema and BWT are associated with airway remodeling in asthmatics. Our simple, semi-quantitative scoring system based on HRCT may be an easy-to-use method for estimating airflow limitation.
尽管接受了最佳治疗,但仍有一部分哮喘患者存在持续性气流受限,即所谓的重塑型哮喘。在高分辨率计算机断层扫描(HRCT)上评估气道重塑结构变化的典型定量评分方法既耗时又费力。因此,临床实践中需要更简便的方法。我们通过比较支气管扩张剂后(BD)-FEV1持续下降的哮喘患者与BD-FEV1随时间恢复正常的患者,评估了一种基于8个HRCT参数的简单半定量方法的临床实用性,并评估了这些参数与BD-FEV1的关系。
根据BD-FEV1在1年中的变化,将哮喘患者(n = 59)分为5个轨迹组(Trs)。在进行9至12个月的基于指南的治疗后,将包括肺气肿、支气管扩张、肺炭末纤维化、支气管壁增厚(BWT)、纤维带、吸气时马赛克样衰减、呼气时气体潴留和小叶中心结节在内的HRCT参数在6个区域分为存在(1)或不存在(0)。
Tr5组(n = 11)年龄较大,BD-FEV1持续下降。与基线BD-FEV1正常的Tr1-3组(n = 36)相比,Tr5组和Tr4组(n = 12)基线BD-FEV1较低但随时间恢复正常,哮喘病程更长,发作频繁,类固醇使用剂量更高。Tr5组的肺气肿和BWT评分高于Tr4组(分别为 = 8.25E-04和 = 0.044)。其他6个参数的评分在各Tr组之间无显著差异。在多变量分析中,BD-FEV1与肺气肿和BWT评分呈负相关(分别为 = 1.70E-04, = 0.006)。
肺气肿和BWT与哮喘患者的气道重塑有关。我们基于HRCT的简单半定量评分系统可能是一种易于使用的评估气流受限的方法。